Expression of ΔDNMT3B variants and its association with estrogen/ progestogen receptor status in breast cancer

Chinese Journal of Cancer Research

Volumn 21, Issue 3, 2009, Pages 229-234

  Liu, Ning Hong ^a   Yang, Lu ^a   Zhuo, Ming Lei ^a   Wang, Jie ^a   Wang, Shu Hang ^a   Zhao, Jun ^a   Bai, Hua ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

DNMT3B variants; Breast cancer; Estrogen receptor; Progestogen receptor; RT PCR

Indexed keywords

DNA METHYLTRANSFERASE 3B; ESTROGEN RECEPTOR; GESTAGEN RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HORMONE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; INTRON; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TISSUE SPECIFICITY;

EID: 68949160948     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-009-0229-y     Document Type: Article

References (14)

1. Robertson KD, Uzvolgyi E, Liang G, et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors [J]. Nucleic Acids Res 1999; 27:2291-2298.
2. Girault I, Tozlu S, Lidereau R, et al. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas [J]. clin cancer Res 2003; 9:4415-4422.
3. Oue N, Kuraoka K, Kuniyasu H, et al. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas. [J]. Oncol Rep 2001; 8:1085-1089.
4. Yakushiji T, Uzawa K, Shibahara T, et al. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. [J]. Int J Oncol 2003; 22:1201-1207.
5. Sato M, Horio Y, Sekido Y, et al. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. [J]. Oncogene 2002; 21:4822-4829.
6. wang L, wang J, Sun S, et al. A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer [J]. Int J Oncol 2006; 29:201-207.
7. WANG Shu-hang, LIU Ning-hong, WANG Jie, et al. Critical role of ΔDNMT3B4/2 in regulating RASSF1A promoter specific DNA methylation in non-small cell lung cancer [J]. Chin Med J 2008; 121:1712-1721.
8. Feinberg AP. The epigenetics of cancer etiology [J]. Semin Cancer Biol 2004; 14:427-432.
9. Herman JG. Epigenetics in lung cancer: Focus on progression and early lesions [J]. Chest 2004; 125(5 Suppl):119S-122S
10. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation [J]. N Engl J Med 2003; 349:2042-2054.
11. Goffin J, Eisenhauer E. DNA methyltransferase inhibitors-state of the art [J]. Ann Oncol 2002; 13:1699-1716.
12. Liang G, Chan MF, Tomigahara Y, et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements [J]. Mol Cell Biol 2002; 22:480-491.
13. Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3B cooperate to silence genes in human cancer cells [J]. Nature 2002; 416:552-556.
14. Wang J, Walsh G, Liu DD, et al. Expression of DeltaDNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer [J]. Cancer Res 2006; 66:8361-8366.